Learn More
Medchemexpress LLC Gemcitabine monophosphate | 116371-67-6 | 99.98% | 343.18 | 10 MG

Supplier: Medchemexpress LLC HY108932100MG
Gemcitabine monophosphate is an active intermediate of Gemcitabine, designed for research use. It exhibits a synergistic anti-cancer effect and can be delivered by formulating it into nanoparticles. It has been shown to induce tumor cell apoptosis and reduce tumor cell proliferation.
- Has a synergistic anti-cancer effect
- Can be delivered by formulating it into nanoparticles
- Induces tumor cell apoptosis (30-40%)
- Reduces tumor cell proliferation (by 8 times)
- Significantly reduces tumor microvessel density (MVD)
- Inhibits tumor mitosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.